TDOC stock dropped significantly in the first seven months of 2021, because of concerns relating to slower revenue growth and competitive threats. Teladoc
Teladoc
Teladoc, Inc. is a telemedicine company that uses telephone and videoconferencing technology to provide on-demand remote medical care via mobile devices, the internet, video and phone. The company had its initial public offering on July 1, 2015.
Will Teladoc stock recover?
Teladoc stock is set for a big comeback, says Goldman Sachs. Teladoc (ticker: TDOC) stock was battered in 2021. Though memberships boomed as the pandemic unfolded in 2020, sending the stock up nearly 139% that year, such gains created a high bar that Teladoc struggled to clear the following year.Feb 11, 2022
Is Teladoc a good stock to buy?
2. It's projecting good growth through at least 2024. Over the next few years, Teladoc probably won't wow investors as it did with its wild run-up in 2020 and 2021, but it's planning to deliver faster-than-average growth nonetheless, and that's another reason its shares could be worth picking up.Mar 5, 2022
What's happening to Teladoc?
Teladoc's market capitalization was cut in half through 2021 and is down to $13.2 billion. That's a 70% collapse from its peak in February. Further, the company's value as a multiple of gross profit is at a multiyear low; the ratio bottomed at 12 during pullbacks in 2018 and 2019.Jan 9, 2022
Is TDOC a strong buy?
Valuation metrics show that Teladoc Health, Inc. may be overvalued. Its Value Score of D indicates it would be a bad pick for value investors. The financial health and growth prospects of TDOC, demonstrate its potential to underperform the market.
Is Teladoc a buy sell or hold?
Teladoc Health has received a consensus rating of Buy. The company's average rating score is 2.58, and is based on 15 buy ratings, 11 hold ratings, and no sell ratings.
Is Teladoc going to rise?
Key Points. Teladoc is still growing its revenue, earnings, and member count. Its strong financials put it in a great position to pursue more growth opportunities. With the stock down heavily, now may be an optimal time to buy it.Jan 11, 2022
Who are Teladoc competitors?
Teladoc Health's top competitors include naviHealth, Lash Group, Amwell, 98point6, MDLIVE, Providence Service Corporation and Sharecare. Teladoc Health is a telehealth company that uses telephone and video conferencing technology to provide on-demand remote medical care via mobile devices, the internet, and video.
Is Teladoc a healthcare stock?
3 Top Healthcare Stocks to Buy for April Shares of Teladoc Health (NYSE: TDOC), GoodRx Holdings (NASDAQ: GDRX), and BioNTech (NASDAQ: BNTX) have been beaten down. It's why shares of Teladoc nearly tripled from January through the end of July of 2020.
TESLA AI DAY
Teladoc Sinks Despite Earnings Beat. Stay Away From TDOC Stock for Now.
What Happened to the Teladoc Stock Price Today?
Teladoc (NASDAQ: TDOC) stock dropped nearly 10% after the telehealth provider reported first-quarter numbers, beating top- and bottom-line expectations.
Meet Luke Lango
By uncovering early investments in hypergrowth industries, Luke Lango puts you on the ground-floor of world-changing megatrends.
